Beyond market averages, investors seeking exceptional growth focus on the art of stock selection. The right picks can significantly contribute to the expansion of your wealth.
As of close of business last night, Cogent Biosciences Inc’s stock clocked out at $37.9, down -3.93% from its previous closing price of $39.45. In other words, the price has decreased by -$3.93 from its previous closing price. On the day, 2.88 million shares were traded. COGT stock price reached its highest trading level at $40.04 during the session, while it also had its lowest trading level at $37.225.
Ratios:
To gain a deeper understanding of COGT’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 6.38 and its Current Ratio is at 6.38. In the meantime, Its Debt-to-Equity ratio is 0.20 whereas as Long-Term Debt/Eq ratio is at 0.19.
On November 10, 2025, Stifel Upgraded its rating to Buy which previously was Hold but kept the price unchanged to $40.
On October 16, 2025, Stifel started tracking the stock assigning a Hold rating and target price of $16.Stifel initiated its Hold rating on October 16, 2025, with a $16 target price.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Jul 10 ’25 when Fairmount Funds Management LLC bought 2,777,777 shares for $9.00 per share. The transaction valued at 24,999,993 led to the insider holds 9,003,418 shares of the business.
Pinnow Cole bought 43,750 shares of COGT for $332,412 on Jan 14 ’25. The Chief Commercial Officer now owns 45,848 shares after completing the transaction at $7.60 per share.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, COGT now has a Market Capitalization of 5817861120 and an Enterprise Value of 5176469504.
Stock Price History:
The Beta on a monthly basis for COGT is 0.50, which has changed by 4.0318875 over the last 52 weeks, in comparison to a change of 0.13329959 over the same period for the S&P500. Over the past 52 weeks, COGT has reached a high of $43.73, while it has fallen to a 52-week low of $3.72. The 50-Day Moving Average of the stock is 35.42%, while the 200-Day Moving Average is calculated to be 178.71%.
Shares Statistics:
It appears that COGT traded 3.19M shares on average per day over the past three months and 2805360 shares per day over the past ten days. A total of 139.83M shares are outstanding, with a floating share count of 125.26M. Insiders hold about 17.62% of the company’s shares, while institutions hold 87.34% stake in the company. Shares short for COGT as of 1764288000 were 14174963 with a Short Ratio of 4.44, compared to 1761868800 on 15053101. Therefore, it implies a Short% of Shares Outstanding of 14174963 and a Short% of Float of 10.3599995.
Earnings Estimates
The performance of Cogent Biosciences Inc (COGT) in the stock market is under the watchful eye of 11.0 analysts actively contributing to its current rating.The consensus estimate for the next quarter is -$0.49, with high estimates of -$0.38 and low estimates of -$0.61.
Analysts are recommending an EPS of between -$1.96 and -$2.47 for the fiscal current year, implying an average EPS of -$2.25. EPS for the following year is -$1.73, with 11.0 analysts recommending between -$0.88 and -$2.25.
